Compare Bristol-Myers Squibb Co (BMY) vs Plug Power Inc (PLUG) Price & Performance

Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.

BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.

Plug Power (PLUG) trades at $2.17, down 2.69% with a bearish technical signal. The company shows persistent financial challenges with negative profit margins (-227.13% net income margin) and cash flow issues, though recent asset sales aim to improve liquidity. Revenue grew to $710M in 2025 but remains unprofitable with significant losses. Analyst sentiment is mixed with 44.7% buy ratings and a $2.92 consensus target, while technical indicators show oversold conditions with RSI at 18.61.

The outlook remains challenging with profitability projected for 2028, but execution risks and continued cash burn pose significant hurdles. Near-term catalysts include $80M liquidity from recent asset sales and project milestones, though elevated short interest at 27.4% reflects skepticism. Investors face high volatility amid the company's turnaround efforts in the competitive hydrogen sector.